NexgenRx Inc. (TSXV:NXG)
Canada · Delayed Price · Currency is CAD 0.6000
0.00 (0.00%)
Aug 7, 2026, 1:08 PM EST
NexgenRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 18.38 | 17.93 | 16.48 | 13.85 | 12.78 | 11.84 | |
Revenue Growth | 9.76% | 8.84% | 18.99% | 8.33% | 7.94% | 7.25% |
Cost of Revenue | 2.82 | 3 | 3.35 | 3.03 | 2.6 | 2.03 |
Gross Profit | 15.56 | 14.93 | 13.12 | 10.82 | 10.18 | 9.81 |
Selling, General & Admin | 11.64 | 11.63 | 10.8 | 9.79 | 8.62 | 6.41 |
Depreciation & Amortization Expenses | 1.14 | 1.22 | 1.27 | 1.31 | 1.41 | 1.33 |
Other Operating Expenses | - | 0.12 | - | - | - | - |
Total Operating Expenses | 12.78 | 12.97 | 12.06 | 11.1 | 10.03 | 7.75 |
Operating Income | 2.78 | 1.96 | 1.06 | -0.28 | 0.16 | 2.07 |
Interest Expense | -0.02 | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 |
Other Non-Operating Income (Expense) | 0.04 | - | - | - | - | - |
Total Non-Operating Income (Expense) | 0.01 | -0.03 | -0.03 | -0.03 | -0.02 | -0.06 |
Pretax Income | 2.8 | 1.94 | 1.03 | -0.31 | 0.13 | 2.01 |
Provision for Income Taxes | 0.64 | 0.65 | 0.41 | 0.03 | 0.16 | -2.01 |
Net Income | 2.16 | 1.29 | 0.61 | -0.33 | -0.02 | 4.02 |
Net Income to Common | 1.99 | 1.29 | 0.61 | -0.33 | -0.02 | 4.02 |
Net Income Growth | 192.41% | 109.86% | - | - | - | 89.91% |
Shares Outstanding (Basic) | 71 | 71 | 71 | 71 | 70 | 70 |
Shares Outstanding (Diluted) | 77 | 77 | 77 | 71 | 70 | 75 |
Shares Change | 0.77% | 0.68% | 8.51% | 0.28% | -6.01% | 0.88% |
EPS (Basic) | 0.03 | 0.01 | 0.01 | -0.01 | - | 0.06 |
EPS (Diluted) | 0.02 | 0.01 | 0.01 | -0.01 | - | 0.05 |
EPS Growth | 300.00% | 180.00% | - | - | - | 86.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 4.42 | 4.68 | 1.06 | 1.2 | 0.68 | 3.7 |
Free Cash Flow Growth | 129.38% | 339.62% | -11.31% | 77.23% | -81.69% | 46.03% |
Free Cash Flow Per Share | 0.06 | 0.06 | 0.01 | 0.02 | 0.01 | 0.05 |
Dividends Per Share | 0.015 | 0.015 | 0.010 | 0.010 | 0.010 | - |
Dividend Growth | 50.00% | 50.00% | 0% | 0% | - | - |
Gross Margin | 84.67% | 83.28% | 79.65% | 78.14% | 79.67% | 82.87% |
Operating Margin | 15.15% | 10.94% | 6.42% | -1.99% | 1.23% | 17.44% |
Profit Margin | 11.74% | 7.19% | 3.73% | -2.40% | -0.18% | 33.93% |
FCF Margin | 24.06% | 26.10% | 6.46% | 8.67% | 5.30% | 31.23% |
EBITDA | 3.93 | 3.18 | 2.32 | 1.03 | 1.56 | 3.4 |
EBITDA Margin | 21.36% | 17.76% | 14.11% | 7.45% | 12.22% | 28.72% |
EBIT | 2.78 | 1.96 | 1.06 | -0.28 | 0.16 | 2.07 |
EBIT Margin | 15.15% | 10.94% | 6.42% | -1.99% | 1.23% | 17.44% |
Effective Tax Rate | 22.79% | 33.37% | 40.14% | -8.82% | 116.66% | -99.91% |